A Conversation About the FDA’s Regulation of Mifepristone
Show: JAMA Clinical Reviews
Mifepristone used with misoprostol is the most common abortion regimen in the US. It is also a focal point of reproductive health policy and politics, with controversy over its legal status and regulation by the US Food and Drug Administration (FDA). Author G. Caleb Alexander, MD, MS, from Johns Hopkins discusses this and more with JAMA Deputy Editor Joseph S. Ross, MD, MHS.
Related Content:
More From Current Show
Heart transplant for patients with advanced heart failure can lead to improved survival and quality of life. Author...
Listen Now Narcolepsy is a chronic neurologic disorder that causes severe daytime sleepiness and impaired quality of life. Author Tom...
Listen Now Respiratory virus vaccine effectiveness and safety for influenza, RSV, and COVID-19 are reviewed, including new evidence, risks, and...
Listen Now Cancer vaccines stimulate immune cells to recognize proteins or mutations found on or within cancer cells, facilitating destruction...
Listen Now Idiopathic normal pressure hydrocephalus (iNPH) affects approximately 1% to 4% of adults aged 65 years and older and...
Listen Now Rheumatoid arthritis can affect any synovial joint and cause irreversible damage, but early diagnosis and treatment with DMARDs...
Listen Now POTS is a chronic autonomic disorder characterized by excessive orthostatic tachycardia and multisystem symptoms that affects an estimated...
Listen Now Naltrexone, acamprosate, disulfiram, and topiramate are effective but underused medications for treatment of alcohol use disorder. Author Stephen...
Listen Now Related Episodes
No related episodes found.
